The Medicines Company (MDCO) - Strategic SWOT Analysis Review
provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations.
The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – GlobalData’s summarization of the company’s business strategy.
SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
The Medicines Company (TMC) is a pharmaceutical company providing medical solutions for improving health conditions in critical care patients. The product portfolio of the company comprises of four marketed products, namely, Angiomax (bivalirudin), Recothrom Thrombin, topical (Recombinant), Cleviprex; and Argatroban and seven pipeline products which include five late-stage development products such as cangrelor, oritavancin, Fibrocaps, RPX-602 and IONSYS (fentanyl iontophoretic transdermal system), and two early stage development product such as MDCO-216,and ALN-PCS. The company also provides acute care generic pharmaceuticals products.
The Medicines Company Key Recent Developments
Jul 23, 2014 The Medicines Company Reports Second Quarter and First Half 2014 Results Jun 05, 2014 New antibiotic could provide single-dose option for skin infections Jun 04, 2014 The Medicines Company Presents Seven Hospital Data Analyses at Leading Health Economics and Outcomes Research Conferences Apr 23, 2014 The Medicines Company Reports First Quarter 2014 Financial Results Apr 18, 2014 Pomerantz Law Firm Announces the Filing of a Class Action Against The Medicines Company and Certain Officers
Reasons to Buy
Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.